Asymchem Laboratories (Tianjin) Co., Ltd. provided group earnings guidance for the year ended December 31, 2021. The revenue of the Company for the year of 2021 was estimated to be in a range between approximately RMB 4,505 million and approximately RMB 4,662 million, representing an increase by a range between approximately 43% and approximately 48% (approximately 52% and approximately 57% if exchange rate impacts excluded) as year-over-year increase, compared with RMB 3,150 million for the year of 2020. Among which, the revenue of the Company for the fourth quarter of 2021 was estimated to be in a range between approximately RMB 1,675 million and approximately RMB 1,730 million, representing an increase by a range between approximately 57% and approximately 62% (approximately 62% and approximately 67% if exchange rate impacts excluded), compared with RMB 1,067 million for the corresponding period in 2020.

The net profit attributable to shareholders of the Company for the year of 2021 was estimated to be in a range between approximately RMB 1,039.80 million and approximately RMB 1,075.90 million, representing an increase by a range between approximately 44% and approximately 49% as year-over-year increase, compared with RMB 722.09 million for the year of 2020. The net profit attributable to shareholders of the Company after deducting the non-recurring profit or loss for the year of 2021 was estimated to be in a range between approximately RMB 908.00 million and approximately RMB 940.20 million, representing an increase by a range between approximately 41% and approximately 46% as year-over-year increase, compared with RMB 643.97 million for the year of 2020. The basic earnings per share of the Company was estimated to be in a range between approximately RMB 4.30 per share and approximately RMB 4.60 per share, compared with RMB 3.10 per share for the year of 2020.